(Q34563901)

3 August 2017

1 reference

title

Statins and osteoporosis: new role for old drugs (English)

1 reference

3 August 2017

0 references

Satyawan B Jadhav

1

1 reference

3 August 2017

Girish Kumar Jain

series ordinal

2

1 reference

3 August 2017

language of work or name

1 reference

1 January 2006

1 reference

Journal of Pharmacy and Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

58

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

3-18

1 reference

Effects of cerivastatin and parathyroid hormone on the lumbar vertebra of aging male Sprague-Dawley rats

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

HMG CoA reductase inhibitors and the skeleton: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The effect of fluvastatin on parameters of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Cardiovascular disease and osteoporosis: is there a link between lipids and bone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The BMP signaling and in vivo bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The role of prenylated small GTP-binding proteins in the regulation of osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Strontium ranelate for the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Withdrawal of cerivastatin from the world market

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins and osteoporosis: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Calcyclin, a Ca2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Role of Cbfa1 in osteoblast differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

A fundamental transcription factor for bone and cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of statins on bone mineral density and bone histomorphometry in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Biological activity of bone morphogenetic proteins (BMP's).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

HMG-CoA reductase inhibitors and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Anabolic agents for treating postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Pravastatin therapy increases procollagen I N-terminal propeptide (PINP), a marker of bone formation in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins and their potential for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Stimulation of bone formation in vitro and in rodents by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statin given perorally to adult rats increases cancellous bone mass and compressive strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Atherogenic high-fat diet reduces bone mineralization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Compactin enhances osteogenesis in murine embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Lipid-lowering agents and the risk of hip fracture in a Medicaid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins decrease bone turnover in postmenopausal women: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Hip fracture risk in statin users--a population-based Danish case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

HMG-CoA reductase inhibitors and the risk of vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin improves fracture healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Effects of simvastatin gels on murine calvarial bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Use of statins and risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Does simvastatin stimulate bone formation in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Mechanism of simvastatin on induction of heat shock protein in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

Statin Use, Bone Mineral Density, and Fracture Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.1.0002

21 January 2018

Identifiers

DOI

10.1211/JPP.58.1.0002

1 reference

3 August 2017

1 reference